Not applicableUnknownNCT03815864What this trial is testingAntibodies and Liver RetransplantationWho this might be right forLiver Transplant FailureAntibody-mediated Rejection London Health Sciences Centre 200
Not applicableEnded earlyNCT04711850What this trial is testingAn Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMRWho this might be right forKidney Transplant Rejection Hansa Biopharma AB 18
Testing effectiveness (Phase 2)Ended earlyNCT01095887What this trial is testingEculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney TransplantationWho this might be right forKidney Transplant Mayo Clinic 6
Testing effectiveness (Phase 2)Study completedNCT02936479What this trial is testingC1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft RejectionWho this might be right forAntibody Mediated Rejection of Kidney Transplant NYU Langone Health 1
Not applicableStudy completedNCT02533596What this trial is testingElimination of Cardiac and Inflammatory Biomarkers and Adipokines by Therapeutic Plasma ExchangeWho this might be right forAntibody-mediated RejectionAutoimmune Reaction Mediated by Immune Complex Hannover Medical School 21
Early research (Phase 1)Not Yet RecruitingNCT06948097What this trial is testingSyk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific AntibodiesWho this might be right forLung Transplantation National Heart, Lung, and Blood Institute (NHLBI) 30
Large-scale testing (Phase 3)Study completedNCT04302805What this trial is testingRATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)Who this might be right forKidney Transplantation Institute for Clinical and Experimental Medicine 17
Testing effectiveness (Phase 2)WithdrawnNCT01035593What this trial is testingRecombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal TransplantationWho this might be right forGraft RejectionKidney Transplantation Pharming Technologies B.V.
Large-scale testing (Phase 3)Looking for participantsNCT06685757What this trial is testingLearn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)Who this might be right forAntibody-mediated Rejection Biogen 120
Testing effectiveness (Phase 2)Study completedNCT00670774What this trial is testingDosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney TransplantWho this might be right forKidney Transplant Mark Stegall 31
Testing effectiveness (Phase 2)WithdrawnNCT02113891What this trial is testingEculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney TransplantationWho this might be right forSubclinical Acute Antibody-mediated Rejection in Kidney Transplantation Assistance Publique - Hôpitaux de Paris
Not applicableUnknownNCT03436134What this trial is testingTreatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma ExchangeWho this might be right forKidney TransplantationAntibody Mediated Rejection University Hospital, Grenoble 16
Testing effectiveness (Phase 2)Study completedNCT02201576What this trial is testingBortezomib in Rejection of Kidney TransplantsWho this might be right forChronic Antibody-mediated Transplant Rejection Assistance Publique - Hôpitaux de Paris 60
Not applicableStudy completedNCT02294032What this trial is testingThe Role of B Cells in Kidney Allograft DysfunctionWho this might be right forKidney; Complications, AllograftTransplantation Infection Loma Linda University 180
Not applicableLooking for participantsNCT07006532What this trial is testingTreatment of Chronic Active Antibody Mediated Rejection With TocilizumabWho this might be right forKidney Transplant Rejection Shahid Beheshti University of Medical Sciences 50
Testing effectiveness (Phase 2)Looking for participantsNCT06503731What this trial is testingEvaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)Who this might be right forAntibody-mediated Rejection argenx 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962What this trial is testingClazakizumab in Highly-HLA Sensitized Patients Awaiting Renal TransplantWho this might be right forKidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more Stanley Jordan, MD 20
Testing effectiveness (Phase 2)Study completedNCT03388008What this trial is testingBelatacept Pilot Study in Lung Transplantation Immunosuppression in Lung TransplantationWho this might be right forLung Transplant RejectionAntibody-mediated Rejection Washington University School of Medicine 27
Not applicableStudy completedNCT05452317What this trial is testingAssess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated RejectionWho this might be right forAntibody-mediated Rejection in Kidney Transplant CSL Behring 52
Large-scale testing (Phase 3)Ended earlyNCT02547220What this trial is testingStudy to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney TransplantWho this might be right forAcute Antibody-Mediated Rejection (AMR) Shire 39